minimal erythema dose (med) to narrow band ultraviolet - b (nb-uvb) broad band ultraviolet-b (bb-uvb) - a pilot study
Clicks: 114
ID: 187770
2002
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
114 views
6 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #173 of 318 articles by views in crystallization of organic compounds: an industrial perspective
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 318 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Phototherapy is an effective treatment for various dermatological conditions. Ultraviolet B (290 - 320nm) is reported effective in the treatment of psoriasis. Narrow band UVB (NB-UVB) is also reported effective in the treatment of psoriasis and vitiligo. To standardize the dosage schedule for NB-UVB we undertook this study to determine the minimal erythema dose (MED) on type IV and Indian skin. On six volunteers tested the MED for NB-UVB ranged between 150mj and 400mj and for BB-UVB ranged between 10mj and 35mj. The mean MED for NB was 300mj and BB was 21 mj, the mean ratio of NB to BB was 1:15. We propose that narrow band UVB is a practical alternative to the conventional broad band UVB and has the advantage over photochemotherapy (PUVA) of being effective without prior administration of psoralen.
| Reference Key |
serish2002indianminimal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Serish;Srinivas C |
| Journal | crystallization of organic compounds: an industrial perspective |
| Year | 2002 |
| DOI |
DOI not found
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.